levated blood pressure (BP) is an important and modifiable risk factor for stroke and coronary heart disease. The risk assessment for cardiovascular disease and treatment of hypertension is largely based on solitary brachial cuff BP reading obtained in clinical settings. Currently, ambulatory BP monitor (ABPM) remains the golden standard of hypertension diagnosis and treatment. However, the ABPM measure is not only costly and is not widely available in some countries, especially in the USA1 because it is poorly reimbursed by third-party payers. In this issue, the brief report by Juraschek et al.2 provides us with more evidence for a more cost-effective method to measure BP, the unattended automatic office BP (AOBP)....
Date:
2020-01
Relation:
American Journal of Hypertension. 2020 Jan;31(1):19-20.
